This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAX F. ROSENBERG, M.D.; ERICH M. UHLMANN, M.D.

AMA Arch Surg. 1959;78(3):376-379.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The beneficial effects of oophorectomy as a palliative procedure in advanced mammary carcinoma have been known for more than 60 years (Schinzinger, 1889; Beatson, 1896). With increasing knowledge of the relationship of certain malignancies to hormonal functions, particularly the estrogendependent carcinomas of the breast, castration by surgical means or by irradiation of the ovaries has become more widely practiced in the management of metastatic cancer of the breast.

In contrast to the acceptance of castration as a palliative measure in the treatment of advanced cancers, the suppression of ovarian function, either by surgery or by irradiation as a prophylactic method before metastases occur, has been a controversial problem. The majority of publications on this subject have been in disfavor of such procedures, as exemplified by Ackerman and del Regato¹ by the statement: "There is no evidence that sterilization results in the prolongation of life or that the systematic sterilization . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Tumor Clinic of Michael Reese Hospital.; Dr. Rosenberg is now Assistant Radiologist, Mount Sinai Hospital.

Footnotes
Submitted for publication Aug. 6, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?